Illumina Inc

Healthcare
$116.09
-1.91(1.62%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$118.46$118.001,612,0713,860,719

Fundamentals

Market Cap$18.49B
P/B Ratio3.2
P/E Ratio-14.3
Enterprise Value$19.57B
Div. Yield0.00%
Book Value37.33
EPS(TTM)-4.77
ROENA
Understand Fundamentals

About the Company

Headquartered in San Diego, California, Illumina, Inc. is a company that develops, manufactures and markets integrated systems for various biotechnological researches. It has a workforce of over 7,300 employees in its 17 commercial and two manufacturing, research and development operations. Internationally it has offices in 11 locations, namely Singapore, China, France, the Netherlands, Korea, Germany, Japan, Canada, Latin America and the United Kingdom. The company conducts research regarding five subjects that are Complex Disease, Agrigenomics, Microbiology, Cellular and Molecular Biology and Cancer. It also offers clinical assistance for oncology, reproductive health and genetic & rare diseases. Illumina’s technology has helped in the generation of over 90% of the world’s sequencing data. It serves seven industries including government agencies, biotechnology companies, pharmaceutical companies, consumer genetics companies, universities and academic research centres, genome centres and hospitals. It offers products such as kits & reagents, instruments, selection tools and software & analysis. Some of its popular products are Illumina COVIDSeq test, AmpliSeq for Illumina, TruSight Oncology 500 product family, Illumina DNA prep, NextSeq 2000 Sequencing System and Illumina RNA Prep with Enrichment. The company was formed in 1998 by five people named Anthony Czarnik, Larry Bock, Mark Chee, David Walt and John Stuelpnagel. It started to acquire several businesses and expand its reach within a year, beginning with Spyder Instruments. Its first system was launched in 2002 called the Illumina BeadLab. Till 2020, the company has acquired Solexa in 2007, Epicentre Biotechnologies in 2011, and Enancio and Grail in 2020. In 2000, Illumina completed its initial public offering (IPO) and started to trade in the NASDAQ stock exchange under ILMN as its ticker symbol. As of 2020, it is a component in both NASDAQ 100 and S&P 500 lists. It is the 47th company in the 2020 Fortune Future 50 companies and the 687th in Fortune 1000 companies’ lists. Forbes has also recognised it in 2020 lists such as Global 2000 and World’s Best Employers. It also made it into the 2021 Forbes list of Just Companies and ranked 67th.;
OrganisationIllumina Inc
IndustryDiagnostics & Research
HeadQuartersSan Diego, CA

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ